Evidence map›Paper›PMID 42775285›Full record

ArticleFASEB bioAdvances2026

Blue Light Exposure Induces Changes Associated With Senescence and Skin Aging in Human Dermal Fibroblasts.

Helen McNish, Mruthyunjaya Swamy Mathapathi, Katarzyna Figlak, Anita Damodaran, Mark Birch-Machin

Abstract read
In one paragraph

Article in FASEB bioAdvances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Helen McNishDermatological Sciences, Translational and Clinical Research Institute Newcastle University London UK.ORCID https://orcid.org/0009-0008-3464-6332
Mruthyunjaya Swamy MathapathiUnilever R&D Bangalore India.ORCID https://orcid.org/0009-0005-8534-9184
Katarzyna FiglakUnilever Bioscience Innovation Hub, King's College London London UK.ORCID https://orcid.org/0000-0003-2089-5967
Anita DamodaranUnilever R&D Bangalore India.ORCID https://orcid.org/0000-0002-9108-9746
Mark Birch-MachinDermatological Sciences, Translational and Clinical Research Institute Newcastle University London UK.ORCID https://orcid.org/0000-0002-2668-2623

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blue light is becoming increasingly prevalent in our daily lives. However, the possible deleterious effects of blue light exposure on the skin have been largely overlooked. We have previously shown that blue light has the ability to induce mitochondrial DNA (mtDNA) damage and dysfunction in human dermal fibroblasts (HDFn). However, whether blue light is able to induce senescence in skin has yet to be investigated. Cellular senescence is a key part of the aging process and is heavily associated with an aging phenotype. Our study involved exposing HDFn to varying doses of blue light before assessing the expression of known senescence markers using both immunofluorescence and gene expression qPCR. We also assessed beta-galactosidase activity using a senescence-associated beta-galactosidase (SA β-gal) staining kit. Blue light induces increased γH2AX expression (

Indexed as

agingblue lightsenescenceskin

Identifiers

PMID42775285
PMCPMC13596750

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.